Overview

Update
Total Equity Funding
$2.84M in 4 Rounds from 1 Investor
Most Recent Funding
$300k Venture on December 4, 2015
Headquarters:
Reno, NV
Description:
Novel breast health screening device and method based on disruptive technology and tissue health science.
Founders:
Categories:
Biotechnology, SaaS, Predictive Analytics
Website:
http://cyrcadiahealth.com/
Social:

Company Details

Update

You are here Home › About

First Warning Systems, Inc. is licensed by its parent company, Lifeline Biotechnologies. The license grants First Warning Systems, Inc. all rights, worldwide, for further product development, regulatory, manufacturing and marketing.

First Warning System™(FWS) is a novel breast health screening device and method based on disruptive technology and tissue health science. The system is a non-invasive breast physiology screening system, much more sensitive and much more cost effective than mammography. The platform has applications for both OB/GYN and primary care in-office use, as well as potential use as an over-the-counter (OTC) diagnostic system.

Funding Rounds (6) - $5.89M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2015$300k / Venture0
Oct, 2014$1M / Angel0
Sep, 2014$2.15M / Debt Financing0
Apr, 2014$540k / Series A1
Jul, 2013$900k / Debt Financing0
Aug, 2012$1M / Series A0

Investors (1)

InvestorRound(s)Partner(s)
Series A-

Current Team (4)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    1325 Airmotive Way, Ste 175-L

    Reno, NV 89502

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos

Portions of this content provided by